NCT06810635Recruiting
Polyphenol Metabotypes in People With Diabetes Type 2
Source: ClinicalTrials.gov · Last updated 23 Mar 2026
Brief summary (registry, in English)
This cross-sectional study seeks to characterize the overall polyphenol metabotype in patients with T2DM in comparison to age-matched individuals without diabetes. Additionally, the study aims to identify factors that influence the polyphenol metabotype (transit time and gut microbial capacity to degrade polyphenols in particular).
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 6 Nov 2024
- Start date
- 4 Mar 2026
- Primary completion date
- Nov 2028
- Lead sponsor
- University Hospital, Ghent
- Diseases
- Type 2 diabetes
- NCT number
- NCT06810635
What you commit to
- Study type: Observational
- Planned participants: 100
- From 4 Mar 2026 to the primary completion date, Nov 2028
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- start of new drug or dietary supplements
- Bariatric surgery
- Heart problems (NYHA 3/4) or previous cardiovascular events
- Intake of coumarin derivatives and direct oral anticoagulant medication
- Immonosuppressants (transplant)
- Antiepileptic drugs
Other illness
- diseases
- Gastrointestinal diseases (inflammatory bowel disease)
- Other forms of diabetes (cystic fibrosis/MODY/T1DM)
- Anti-cancer treatment: chemo-/immunotherapy
Other
- pregnancy of breastfeeding
- in last month
- acute use of anti/pre/probiotics
- major changes in diet
- major lifestyle changes
- Liver problems: non-alcohol steatohepatitis (NASH) and cirrhosis
- Lung problems (COPD - GOLD 3/4), cystic fibrosis
- Uncontrolled thyroid function disruption in the past 6 months
Who the study is looking for
- all participants
- between 40-85 years
- age-matched individuals without diabetes
- BMI between 18.5-30
- no metabolic syndrome
- persons with T2DM
- at leats 2 years of clinical diagnoses of T2DM
- stable medication use for at least 1 month
Age in the registry: 40 years to 85 years · Sex: All · Accepts healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Ghent University Coordinator of this site? Confirm its status | Ghent | Belgium | Not yet recruiting |
| Department of rehabilitation sciences - UGent Coordinator of this site? Confirm its status | Ghent | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.